Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication

References

• Adelufosi, A. O., Adebowale, T. O., Abayomi, O., & Mosanya, J. T. (2012). Medication adherence and quality of life among Nigerian outpatients with schizophrenia. General Hospital Psychiatry, 34(1), 72–79. doi:10.1016/j.genhosppsych.2011.09.001
   PubMed Web of Science ®Google Scholar
• Andreasen, N. C., Pressler, M., Nopoulos, P., Miller, D., & Ho, B.-C. (2010). Antipsychotic dose equivalents and dose-years: A standardized method for comparing exposure to different drugs. Biological Psychiatry, 67(3), 255–262. doi:10.1016/j.biopsych.2009.08.040
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, fourth edition: DSM-IV-TR^®. American Psychiatric Pub.
   Google Scholar
• Baggaley, M. (2008). Sexual dysfunction in schizophrenia: Focus on recent evidence. Human Psychopharmacology: Clinical and Experimental, 23(3), 201–209. doi:10.1002/hup.924
   PubMed Web of Science ®Google Scholar
• Bitter, I., Basson, B. R., & Dossenbach, M. R. (2005). Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. International Clinical Psychopharmacology, 20(1), 19–21. doi:10.1097/00004850-200501000-00004
   PubMed Web of Science ®Google Scholar
• Bobes, J., Garc A-Portilla, M. P., Rejas, J., Hern Ndez, G., Garcia-Garcia, M., Rico-Villademoros, F., & Porras, A. (2003). Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: The results of the EIRE study. Journal of Sex &Amp; Marital Therapy, 29(2), 125–147.
   PubMed Web of Science ®Google Scholar
• Byerly, M. J., Nakonezny, P. A., Bettcher, B. M., Carmody, T., Fisher, R., & Rush, A. J. (2006). Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophrenia Research, 86(1–3), 244–250. doi:10.1016/j.schres.2006.04.005
   PubMed Web of Science ®Google Scholar
• Dervaux, A., & El Omari, F. (2005). Sexual dysfunction in schizophrenics patients, the role of antipsychotics. Presse médicale (Paris, France: 1983), 34(7), 529–532.
   PubMed Web of Science ®Google Scholar
• Dossenbach, M., Dyachkova, Y., Pirildar, S., Anders, M., Khalil, A., Araszkiewicz, A., … Treuer, T. (2006). Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. European Psychiatry: The Journal of the Association of European Psychiatrists, 21(4), 251–258. doi:10.1016/j.eurpsy.2005.12.005
   PubMed Web of Science ®Google Scholar
• Dossenbach, M., Hodge, A., Anders, M., Molnár, B., Peciukaitiene, D., Krupka-Matuszczyk, I., … McBride, M. (2005). Prevalence of sexual dysfunction in patients with schizophrenia: International variation and underestimation. The International Journal of Neuropsychopharmacology, 8(2), 195–201. doi:10.1017/S1461145704005012
   PubMed Web of Science ®Google Scholar
• Fakhoury, W. K., Wright, D., & Wallace, M. (2001). Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology, 16(3), 153–162. doi:10.1097/00004850-200105000-00004
   PubMed Web of Science ®Google Scholar
• Finn, S. E., Bailey, J. M., Schultz, R. T., & Faber, R. (1990). Subjective utility ratings of neuroleptics in treating schizophrenia. Psychological Medicine, 20(04), 843–848. doi:10.1017/S0033291700036539
   PubMedGoogle Scholar
• Fleischhacker, W. W., Meise, U., Günther, V., & Kurz, M. (1994). Compliance with antipsychotic drug treatment: Influence of side effects. Acta Psychiatrica Scandinavica, 89 (Supplementum 382), 11–15. doi:10.1111/j.1600-0447.1994.tb05859.x
   Google Scholar
• Fujii, A., Yasui-Furukori, N., Sugawara, N., Sato, Y., Nakagami, T., Saito, M., & Kaneko, S. (2010). Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(2), 288–293. doi:10.1016/j.pnpbp.2009.11.022
   PubMed Web of Science ®Google Scholar
• Ghadirian, A. M., Chouinard, G., & Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. The Journal of Nervous and Mental Disease, 170(8), 463–467.
   PubMed Web of Science ®Google Scholar
• Haddad, P. M., & Sharma, S. G. (2007). Adverse effects of atypical antipsychotics: Differential risk and clinical implications. CNS Drugs, 21(11), 911–936.
   PubMed Web of Science ®Google Scholar
• Haddad, P. M., & Wieck, A. (2004). Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management. Drugs, 64(20), 2291–2314. doi:10.2165/00003495-200464200-00003
   PubMed Web of Science ®Google Scholar
• Hanssens, L., L’Italien, G., Loze, J.-Y., Marcus, R. N., Pans, M., & Kerselaers, W. (2008). The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: Results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry, 8, 95. doi:10.1186/1471-244X-8-95
   PubMed Web of Science ®Google Scholar
• Kelly, D. L., & Conley, R. R. (2004). Sexuality and schizophrenia: A review. Schizophrenia Bulletin, 30(4), 767–779.
   PubMed Web of Science ®Google Scholar
• Kelly, D. L., & Conley, R. R. (2006). A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology, 31(3), 340–346. doi:10.1016/j.psyneuen.2005.08.010
   PubMed Web of Science ®Google Scholar
• Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. The Journal of Clinical Psychiatry, 63(10), 892–909. doi:10.4088/JCP.v63n1007
   PubMed Web of Science ®Google Scholar
• Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., … Naber, D. (2004). Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry: The Journal of the Association of European Psychiatrists, 19(7), 415–422. doi:10.1016/j.eurpsy.2004.06.031
   PubMed Web of Science ®Google Scholar
• Lewis, J., Scott, E. (1997). The sexual education needs of those disabled by mental…. Psychiatric Rehabilitation Journal, 21(2), 164. doi:10.1037/h0095323
   Web of Science ®Google Scholar
• Lingjaerde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica, 76(s334), 1–100. doi:10.1111/j.1600-0447.1987.tb10566.x
   PubMedGoogle Scholar
• Mahmoud, A., Hayhurst, K. P., Drake, R. J., & Lewis, S. W. (2011). Second generation antipsychotics improve sexual dysfunction in schizophrenia: A randomised controlled trial. Schizophrenia Research and Treatment, 2011, 596898. doi:10.1155/2011/596898
   PubMedGoogle Scholar
• Mahmoud, A., Hayhurst, K. P., Drake, R. J., & Lewis, S. W. (2012). Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment. International Journal of Psychiatry in Clinical Practice, 16(2), 148–152. doi:10.3109/13651501.2011.625122
   PubMed Web of Science ®Google Scholar
• Malik, P. (2007). Sexual dysfunction in schizophrenia. Current Opinion in Psychiatry, 20(2), 138–142. doi:10.1097/YCO.0b013e328017f6c4
   PubMed Web of Science ®Google Scholar
• Mir, A., Shivakumar, K., Williamson, R. J., McAllister, V., O'Keane, V., & Aitchison, K. J. (2008). Change in sexual dysfunction with aripiprazole: A switching or add-on study. Journal of Psychopharmacology, 22(3), 244–253. doi:10.1177/0269881107082901
   PubMed Web of Science ®Google Scholar
• Montejo, A. L., & Rico-Villademoros, F. (2008). Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. Journal of Sex & Marital Therapy, 34(3), 227–239. doi:10.1080/00926230701866125
   PubMed Web of Science ®Google Scholar
• Montejo, A. L., Riesgo, Y., Luque, J., Barber, I., & Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. (2010). Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole. Actas Españolas de Psiquiatría, 38(1), 13–21.
   PubMed Web of Science ®Google Scholar
• Nebhinani, N., Grover, S., & Avasthi, A. (2012). Sexual dysfunction in male subjects receiving trifluoperazine, risperidone, or olanzapine: Rates vary with assessment questionnaire. The Primary Care Companion to CNS Disorders, 14(2). doi:10.4088/PCC.11m01199
   Google Scholar
• Oyekanmi, A. K., Adelufosi, A. O., Abayomi, O., & Adebowale, T. O. (2012). Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications. BMC Research Notes, 5(1), 267. doi:10.1186/1756-0500-5-267
   PubMedGoogle Scholar
• Paton, C., Lelliott, P., Harrington, M., Okocha, C., Sensky, T., & Duffett, R. (2003). Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. Journal of Psychopharmacology, 17(2), 223–229. doi:10.1177/0269881103017002012
   PubMed Web of Science ®Google Scholar
• Perkins, D. O. (2002). Predictors of noncompliance in patients with schizophrenia. The Journal of Clinical Psychiatry, 63(12), 1121–1128.
   PubMed Web of Science ®Google Scholar
• Rosenberg, K. P., Bleiberg, K. L., Koscis, J., & Gross, C. (2003). A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: Impact on compliance. Journal of Sex & Marital Therapy, 29(4), 289–296. doi:10.1080/00926230390195524
   PubMed Web of Science ®Google Scholar
• Serretti, A., & Chiesa, A. (2011). A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. International Clinical Psychopharmacology, 26(3), 130–140. doi:10.1097/YIC.0b013e328341e434
   PubMedGoogle Scholar
• Smith, S., O'Keane, V., & Murray, R. (2002). Sexual dysfunction in patients taking conventional antipsychotic medication. British Journal of Psychiatry, 181(01), 49–55.
   PubMedGoogle Scholar
• Taylor, D., Kapur, S., & Taylor, D. (2012). The Maudsley prescribing guidelines in psychiatry. Retrieved from http://site.ebrary.com/lib/uqat/Doc?id=10531429
   Google Scholar
• Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241–247. doi:10.1016/S0920-9964(99)00130-9
   PubMed Web of Science ®Google Scholar
• Voermans, J. M., Van, H. L., Peen, J., & Hengeveld, M. W. (2012). Is there adequate discussion between psychiatrists and their patients regarding patients’ sexual problems? Tijdschrift Voor Psychiatrie, 54(1), 9–16.
   PubMedGoogle Scholar
• Wasow, M. (1980). Sexuality and the institutionalized mentally ill. Sexuality and Disability, 3(1), 3–16. doi:10.1007/BF01102598
   Web of Science ®Google Scholar
• Zhang, X. R., Zhang, Z. J., Zhu, R. X., Yuan, Y. G., Jenkins, T. A., & Reynolds, G. P. (2011). Sexual dysfunction in male schizophrenia: Influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes. Pharmacogenomics, 12(8), 1127–1136. doi:10.2217/pgs.11.46
   PubMed Web of Science ®Google Scholar